Stock research on global mid-cap companies

Evaluate Research

Evaluate Research provides institutional quality stock research on small-cap and  mid-cap companies on a global basis, thus helping connect investors with the company.

At Evaluate Research, we provide free of cost to all investors a 20-25 page Initiation Report which evaluates in great detail all aspects of the company:  growth opportunities, catalysts, business description, competitive positioning, SWOT analysis, risks, etc.  In addition, we determine specific price targets for the company based on detailed 5-year complete forecasts of financial statements including IS, BS, CF, ratios, etc.  Finally, whereas many sell-side brokers offer sketchy and irregular ongoing maintenance research of companies, if not outright dropped or termination of coverage, at Evaluate Research we systematically monitor and regularly publish Update Notes covering quarterly earnings, major corporate events, etc.

All of the research reports are broadly and freely disseminated globally to leading Fund Managers and analysts who invest specifically in mid-size equities, and also on leading investment information platforms including: Bloomberg, Thomson Reuters, FactSet etc.

Stock research on global mid-cap companies, Evaluate Research

Equity Bottom-Up

<ul>
<li>For FY2022–Total Buyback of 5.9 million shares (HK$18.3 million) at average price of $3.10</li>
<li>Funds Management Business – Extended Platform to provide Family Office Solutions</li>
<li>Funds Management Unit – Total AUM increased 21% to US$975 million in 2022 with external capital accounting for 46.5%</li>
</ul>


For FY2022–Total Buyback of 5.9 million shares (HK$18.3 million) at average price of $3.10
Funds Management Business – Extended Platform to provide Family Office Solutions
Funds Management Unit – Total AUM increased 21% to US$975 million in 2022 with external capital accounting for 46.5%


SHK 86_HK: Dividend Yield 8%, P/E 2.0x, P/B 0.27x

Sun Hung Kai

SHK 86_HK: Dividend Yield 8%, P/E 2.0x, P/B 0.27x